{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:37:26Z","timestamp":1791823046533,"version":"4.3.4"},"reference-count":128,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.pnpbp.2004.05.033","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T05:37:34Z","timestamp":1091165854000},"page":"913-922","source":"Crossref","is-referenced-by-count":124,"title":["Proposal for a noradrenaline hypothesis of schizophrenia"],"prefix":"10.1016","volume":"28","author":[{"given":"Kenichi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh","family":"Hornykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2004.05.033_BIB1","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF00426474","article-title":"Effects of 6-hydroxydopamine lesions of locus coeruleus on startle in rats","volume":"73","author":"Adams","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0301-0082(77)90016-8","article-title":"The locus coeruleus: neurobiology of a central noradrenergic nucleus","volume":"9","author":"Amaral","year":"1977","journal-title":"Prog. Neurobiol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/ajp.139.3.297","article-title":"Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms","volume":"139","author":"Andreasen","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpsyc.1992.01820120031006","article-title":"Hypofrontality in neuroleptic-na\u0131\u0308ve patients and in patients with chronic schizophrenia","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00433802","article-title":"Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia","volume":"72","author":"Angrist","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF00432248","article-title":"Partial improvement in negative schizophrenic symptoms after amphetamine","volume":"78","author":"Angrist","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"Comprehensive psychopathological rating scale","volume":"271","author":"\u00c5sberg","year":"1978","journal-title":"Acta Psychiatr. Scand., Suppl"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1523\/JNEUROSCI.01-08-00876.1981","article-title":"Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep\u2013waking cycle","volume":"1","author":"Aston-Jones","year":"1981","journal-title":"J. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine. A novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0301-0511(84)90003-6","article-title":"Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituation","volume":"18","author":"Bartfai","year":"1984","journal-title":"Biol. Psychol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0361-9230(81)80060-3","article-title":"Comparison of behavioral changes in cats treated with intracerebro-ventricular 6-hydroxydopamine and reserpine","volume":"6","author":"Beleslin","year":"1981","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1176\/ajp.144.10.1277","article-title":"A relationship between anatomical and physiological brain pathology in schizophrenia: lateral cerebral ventricular size predicts cortical blood flow","volume":"144","author":"Berman","year":"1987","journal-title":"Am. J. Psychiatr"},{"issue":"Suppl. 280","key":"10.1016\/j.pnpbp.2004.05.033_BIB14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/acps.1980.61.s280.63","article-title":"Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness","author":"Bird","year":"1980","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1152\/ajplegacy.1975.228.4.1276","article-title":"Hemodynamic effects of systemic and central administration of clonidine in the monkey","volume":"228","author":"Bolme","year":"1975","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB16","first-page":"1377","article-title":"Catecholamines and their receptors in blood: evidence for alterations in schizophrenia","volume":"19","author":"Bondy","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB17","first-page":"509","article-title":"Cocaine-induced psychosis","volume":"52","author":"Brady","year":"1991","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB18","first-page":"633","article-title":"The use of monoamine oxidase inhibitor in schizophrenia","volume":"15","author":"Brenner","year":"1980","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000118205","article-title":"Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls","volume":"14","author":"Bridge","year":"1985","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1037\/0735-7044.109.5.903","article-title":"Specific effects of idazoxan in a distraction task: evidence that endogenous norepinephrine plays a role in selective attention in rats","volume":"109","author":"Bunsey","year":"1995","journal-title":"Behav. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB21","series-title":"Catecholamines: Basic and Clinical Frontiers","first-page":"4","article-title":"The impact of catecholamine research in medical science and practice","author":"Carlsson","year":"1979"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB22","first-page":"60","article-title":"Alpha methyldopa\u2013chlorpromazine interaction in schizophrenia patients","volume":"15","author":"Chouinard","year":"1973","journal-title":"Curr. Ther. Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00427744","article-title":"The activities of brain dopamine-\u03b2-hydroxylase and catechol-o-methyl transferase in schizophrenics and controls","volume":"59","author":"Cross","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.280.6207.66","article-title":"Molecular pathology of schizophrenia: more than one disease process?","volume":"280","author":"Crow","year":"1980","journal-title":"Br. Med. J"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.134.3.249","article-title":"Monoamine mechanisms in chronic schizophrenia: post mortem neurochemical findings","volume":"134","author":"Crow","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00005053-198506000-00001","article-title":"Problems in classification of schizophrenics as neuroleptic responders and nonresponders","volume":"173","author":"Csernansky","year":"1985","journal-title":"J. Nerv. Ment. Dis"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000117988","article-title":"Plasma noradrenaline and clinical psychopathology in schizophrenia. A correlation analysis","volume":"10","author":"Dajas","year":"1983","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.1987.tb11220.x","article-title":"Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms","volume":"90","author":"De Sarro","year":"1987","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(86)90964-9","article-title":"Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents","volume":"375","author":"Elam","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB30","series-title":"Limbic Mechanisms","first-page":"333","article-title":"Monoaminergic systems in the human limbic brain","author":"Farley","year":"1978"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.644310","article-title":"Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain","volume":"200","author":"Farley","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.0953-816x.2001.01471.x","article-title":"Dopamine and noradrenaline efflux in the rat prefrontal cortex after classical aversive conditioning to an auditory cue","volume":"13","author":"Feenstra","year":"2001","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.ne.10.030187.000435","article-title":"Extrathalamic modulation of cortical function","volume":"10","author":"Foote","year":"1987","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB34","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1073\/pnas.77.5.3033","article-title":"Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal","volume":"77","author":"Foote","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0447.1982.tb00819.x","article-title":"Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs","volume":"65","author":"Freedman","year":"1982","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB137","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/nlme.1996.0067","article-title":"Norepinephrine release in the amygdala in response to footshock stimulation","volume":"66","author":"Galvez","year":"1996","journal-title":"Neurobiol. Learn. Mem"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(83)90012-4","article-title":"Dopamine and noradrenaline in the cerebrospinal fluid of schizophrenic patients","volume":"8","author":"Gattaz","year":"1983","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(89)90006-1","article-title":"Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study","volume":"27","author":"Gay","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.1987.01800220068010","article-title":"Noradrenergic function in schizophrenia","volume":"44","author":"Glazer","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.137.4.346","article-title":"Noradrenergic overactivity in chronic schizophrenia: evidence based in cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations","volume":"137","author":"Gomes","year":"1980","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1469-8986.1975.tb03064.x","article-title":"Evidence of high and low level of physiological arousal in schizophrenics","volume":"12","author":"Gruzelier","year":"1975","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427464","article-title":"Schizophrenia: a theory","volume":"49","author":"Hartmann","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1037\/0021-843X.102.1.39","article-title":"Reduced regional brain glucose metabolism assessed by positron emission tomography in electrodermal nonresponder schizophrenics: a pilot study","volume":"102","author":"Hazlett","year":"1993","journal-title":"J. Abnorm. Psychology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.1094539","article-title":"Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups","volume":"189","author":"Hobson","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00592678","article-title":"Autonomic and psychic effects of yohimbine hydrochloride","volume":"2","author":"Holmberg","year":"1961","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.181.4095.179","article-title":"Eye tracking patterns in schizophrenia","volume":"181","author":"Holzman","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB46","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/archpsyc.1976.01770120019001","article-title":"Smooth pursuit eye movements, attention and schizophrenia","volume":"33","author":"Holzman","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB47","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/299484a0","article-title":"Brain catecholamines in schizophrenia\u2014a good case for noradrenaline","volume":"299","author":"Hornykiewicz","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0079-6123(08)60639-1","article-title":"Brain noradrenaline and schizophrenia","volume":"65","author":"Hornykiewicz","year":"1986","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0079-6123(08)60029-1","article-title":"The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain","volume":"58","author":"H\u00f6rtnagl","year":"1983","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB50","volume":"vol. 8","year":"1977"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1973.01750320023004","article-title":"Provocation of schizophrenic symptoms by intravenous administration of methylphenidate","volume":"28","author":"Janowsky","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB52","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of the antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000118821","article-title":"Plasma free 3-methoxy-4-hydroxyphenylglycolin acute schizophrenics before and after treatment","volume":"25","author":"Kaneko","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2190\/LMEL-L5HQ-PEQV-VYCJ","article-title":"l-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental study","volume":"15","author":"Kay","year":"1985","journal-title":"Int. J. Psychiatry Med"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB56","first-page":"711","article-title":"Increased noradrenaline levels in CSF and plasma of schizophrenic patients","volume":"17","author":"Kemali","year":"1982","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0447.1985.tb05046.x","article-title":"Relationship between CSF noradrenaline levels, C-EEG indicators of activation and psychosis ratings in drug-free schizophrenic patients","volume":"71","author":"Kemali","year":"1985","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0278-5846(90)90063-M","article-title":"Factors associated with increased noradrenaline levels in schizophrenic patients","volume":"14","author":"Kemali","year":"1990","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB59","series-title":"The Neurosciences, 2nd Study Program","first-page":"324","article-title":"The biogenic amines in the central nervous system: their possible roles in arousal, emotion, and learning","author":"Kety","year":"1970"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB60","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0006-3223(93)90019-A","article-title":"Electrodermal responsiveness, clinical variables, and brain imaging in male chronic schizophrenics","volume":"33","author":"Kim","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB61","first-page":"1845","article-title":"Catecholamines and metabolites in the brains of psychotics and normals: post-mortem studies","volume":"vol. 2","author":"Kleinman","year":"1979"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB62","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archpsyc.1988.01800330072009","article-title":"Plasma 3-methoxy-4-hydroxy-phenyl-glycol changes associated with clinical state and schizophrenic subtype","volume":"45","author":"Ko","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00426636","article-title":"Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration","volume":"59","author":"Kokkinidis","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archpsyc.1989.01810100064012","article-title":"Anti-depressants in \u2018depressed\u2019 schizophrenic inpatients","volume":"46","author":"Kramer","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB65","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1176\/ajp.126.9.1213","article-title":"Sleep disturbance in acute schizophrenia patient","volume":"126","author":"Kupfer","year":"1970","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00403681","article-title":"Comparison of amphetamine sulfate and caffeine citrate in man","volume":"14","author":"Lader","year":"1969","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.7350667","article-title":"Schizophrenia: elevated cerebrospinal fluid norepinephrine","volume":"207","author":"Lake","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB68","series-title":"Developmental Neuropsychobiology","first-page":"119","article-title":"Do neurotransmitters, neurotumors, and hormones specify critical periods?","author":"Lauder","year":"1986"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0301-0082(74)90002-1","article-title":"On the roles of dopamine and noradrenaline in animal behaviours","volume":"3","author":"Laverty","year":"1974","journal-title":"Prog. Neurobiol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(99)00122-X","article-title":"Quantitative characterization of eye tracking dysfunction in schizophrenia","volume":"42","author":"Levy","year":"2000","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB71","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/schbul\/19.2.371","article-title":"Neurochemistry and neuroendocrinology of schizophrenia: a selective review","volume":"19","author":"Lieberman","year":"1993","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004714-199308000-00006","article-title":"Idazoxan, an \u03b12 antagonist, augments fluphenazine in schizophrenic patients: a pilot study","volume":"13","author":"Litman","year":"1993","journal-title":"J. Clin. Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB73","first-page":"45","article-title":"Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites","volume":"39","author":"Maas","year":"1984","journal-title":"Adv. Biochem. Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-1781(95)02354-Y","article-title":"Type I and type II schizophrenia: relations between tonic electrodermal activity and clinical ratings before and after haloperidol treatment","volume":"57","author":"Maina","year":"1995","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archpsyc.57.7.637","article-title":"Schizophrenia as a disorder of developmentally reduced synaptic connectivity","volume":"57","author":"McGlashan","year":"2000","journal-title":"Arch. Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.ne.02.030179.000553","article-title":"Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems","volume":"2","author":"Moore","year":"1979","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB77","first-page":"R784","article-title":"Cardiovascular change and hypothalamic norepinephrine release in response to environmental stress","volume":"264","author":"Nakata","year":"1993","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-1781(83)90003-3","article-title":"Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers","volume":"9","author":"Nyback","year":"1983","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB80","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1192\/bjp.136.4.384","article-title":"The disabilities of chronic schizophrenia\u2014their nature and the factors contributing to their development","volume":"136","author":"Owens","year":"1980","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00427835","article-title":"Klinishe-psychopathologische Beobachtungen bei chronishem Missbranch von Ephedrine and verwandtem Substanzen","volume":"206","author":"Panse","year":"1964","journal-title":"Arch. Psychiatr. Zeitshr. Ges. Neurol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB82","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey","volume":"44","author":"Pifl","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB83","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpsyc.1975.01760260127011","article-title":"Cerebrospinal fluid amine metabolites in acute schizophrenia","volume":"32","author":"Post","year":"1975","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB84","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-8993(86)90371-9","article-title":"Single unit activity of locus coeruleus neurons in the freely moving cat: II. Conditioning and pharmacologic studies","volume":"371","author":"Rasmussen","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB85","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.181.4106.1256","article-title":"Behavior of free-ranging macaques after intraventricular 6-hydroxydopamine","volume":"181","author":"Redmond","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000071462","article-title":"Ubiquitous embryonic expression of the norepinephrine transporter","volume":"25","author":"Ren","year":"2003","journal-title":"Dev. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB87","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0006-3223(96)00492-1","article-title":"Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome","volume":"42","author":"Ross","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0924-977X(90)90007-W","article-title":"EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms","volume":"1","author":"Saletu","year":"1990","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB89","first-page":"429","article-title":"Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis","volume":"18","author":"Sato","year":"1983","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB90","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/oxfordjournals.schbul.a033386","article-title":"Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation","volume":"25","author":"Serper","year":"1999","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB91","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/378176a0","article-title":"A functional neuroanatomy of hallucinations in schizophrenia","volume":"378","author":"Sibersweig","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pnpbp.2004.05.033_BIB92","first-page":"331","article-title":"The use of antidepressants for negative symptoms in a subset of schizophrenic patients","volume":"27","author":"Siris","year":"1991","journal-title":"Psychopharmacol. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB93","first-page":"315","article-title":"Brain monoamines in the rhesus monkey during long-term neuroleptic administration","volume":"24","author":"Shannak","year":"1980","journal-title":"Adv. Biochem. Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB94","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1126\/science.171.3975.1032","article-title":"Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine","volume":"171","author":"Stein","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB95","first-page":"1045","article-title":"The effect of pimozide on CSF norepinephrine in schizophrenia","volume":"138","author":"Sternberg","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archpsyc.1983.01790060041005","article-title":"CSF dopamine \u03b2-hydroxylase in schizophrenia","volume":"40","author":"Sternberg","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00215471","article-title":"Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology","volume":"92","author":"Svensson","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB98","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"\u03b1-Adrenoceptor modulation hypothesis of antipsychotic atypicality","volume":"27","author":"Svensson","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB99","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-1781(94)90006-X","article-title":"Selective effects of antipsychotic medications on eye-tracking performance in schizophrenia","volume":"54","author":"Sweeney","year":"1994","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0006-8993(91)90902-8","article-title":"Noradrenaline release in the rat amygdala is increased by stress: studies with intracerebral microdialysis","volume":"544","author":"Tanaka","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(99)00163-2","article-title":"Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome","volume":"45","author":"Tandon","year":"2000","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB102","first-page":"163","article-title":"Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat: I. Modification of norepinephrine turnover","volume":"163","author":"Thierry","year":"1968","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB103","first-page":"531","article-title":"Chronic schizophrenia-like states in methamphetamine psychosis","volume":"44","author":"Tomiyama","year":"1990","journal-title":"Jpn. J. Psychiatry Neurol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB104","series-title":"Psychopharmacology: The Third Generation of Progress","first-page":"745","article-title":"Biochemical instability in schizophrenia: I. The norepinephrine system","author":"Van Kammen","year":"1987"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB105","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.6133351","article-title":"Dopamine-\u03b2-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy","volume":"220","author":"Van Kammen","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB106","series-title":"Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications","first-page":"113","article-title":"Noradrenergic mechanisms, state dependency and negative symptoms in schizophrenia","author":"Van Kammen","year":"1991"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB107","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.schbul.a033327","article-title":"A candidate molecule approach defining developmental pathology in schizophrenia","volume":"24","author":"Weickert","year":"1998","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archpsyc.1980.01780140013001","article-title":"Cerebral ventricular enlargement in chronic schizophrenia on association with a poor response to treatment","volume":"37","author":"Weinberger","year":"1980","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB109","first-page":"323","article-title":"Why do neurotransmitters act like growth factors?","volume":"5","author":"Weiss","year":"1998","journal-title":"Prog. Dev. Neurobiol"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.1979.tb00261.x","article-title":"Monoamines and monoamine metabolites in brains from demented schizophrenics","volume":"60","author":"Winblad","year":"1979","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB111","series-title":"Schizophrenia; Towards a New Synthesis","first-page":"1","article-title":"Clinical concepts of schizophrenia","author":"Wing","year":"1978"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB112","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1126\/science.181.4097.344","article-title":"Dopamine-\u03b2-hydroxylase deficits in the brains of schizophrenic patients","volume":"181","author":"Wise","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB113","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.187.4174.370","article-title":"Dopamine \u03b2-hydroxylase activity in brains of chronic schizophrenic patients","volume":"187","author":"Wise","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-3956(74)90092-2","article-title":"Postmortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia","volume":"11","author":"Wise","year":"1974","journal-title":"J. Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050351","article-title":"Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting","volume":"132","author":"Witte","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB116","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-3223(94)90629-7","article-title":"Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology","volume":"36","author":"Wolkins","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB117","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1126\/science.1111112","article-title":"Dopamine \u03b2-hydroxylase activity in brains of chronic schizophrenic patients","volume":"187","author":"Wyatt","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB118","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005053-198102000-00005","article-title":"The schizophrenia syndrome. Examples of biological tools for subclassification","volume":"169","author":"Wyatt","year":"1981","journal-title":"J. Nerv. Ment. Dis"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB119","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0304-3940(89)90211-5","article-title":"Increased firing of locus coeruleus neurons associated with preparatory set in rats","volume":"106","author":"Yamamoto","year":"1989","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(90)90632-C","article-title":"Skin conductance response after 6-hydroxydopamine lesion of the central noradrenergic system in cats","volume":"28","author":"Yamamoto","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB121","first-page":"185","article-title":"An early relapse-treatment of schizophrenia with oxypertine","author":"Yamamoto","year":"1993","journal-title":"World Fed. Ment. Health, World Cong. Abst"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB122","series-title":"The Biology of Schizophrenia","first-page":"135","article-title":"Reproduction of psychophysiological signs in animals; implication for a noradrenaline hypothesis of schizophrenia","author":"Yamamoto","year":"1994"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-9964(94)90095-7","article-title":"Functional influence of the central noradrenergic system on the skin conductance activity in rats","volume":"13","author":"Yamamoto","year":"1994","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB124","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0361-9230(94)90167-8","article-title":"Possible noradrenergic dysfunction in schizophrenia","volume":"35","author":"Yamamoto","year":"1994","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB125","first-page":"528","article-title":"The action of l-dopa on schizophrenic patients (a preliminary report)","volume":"12","author":"Yaryura-Jobias","year":"1970","journal-title":"Curr. Ther. Res"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB126","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF01951769","article-title":"Stress-induced increase in noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis","volume":"46","author":"Yokoo","year":"1990","journal-title":"Experientia"},{"key":"10.1016\/j.pnpbp.2004.05.033_BIB127","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0447.1981.tb00645.x","article-title":"dl-Propranolol and chlorpromazine following admission for schizophrenia: a controlled comparison","volume":"63","author":"Yorkston","year":"1981","journal-title":"Acta Psychiat. Scand"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584604000910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584604000910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:32:22Z","timestamp":1682739142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584604000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":128,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0278584604000910"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2004.05.033","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}